相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin
Roland E. Schmieder et al.
CLINICAL RESEARCH IN CARDIOLOGY (2015)
Renal Hemodynamic Effects of Serelaxin in Patients With Chronic Heart Failure A Randomized, Placebo-Controlled Study
Adriaan A. Voors et al.
CIRCULATION-HEART FAILURE (2014)
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2014)
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2014)
The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure
Mattia A. E. Valente et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Effect of Serelaxin on Mode of Death in Acute Heart Failure Results From the RELAX-AHF Study
G. Michael Felker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein
Valeria Cernaro et al.
MEDICINAL RESEARCH REVIEWS (2014)
Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors
Joao Pedro Ferreira et al.
CLINICAL RESEARCH IN CARDIOLOGY (2013)
RELAX-AHF: consistency across subgroups and new hypotheses generated
Roland E. Schmieder
EUROPEAN HEART JOURNAL (2013)
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
Marco Metra et al.
EUROPEAN HEART JOURNAL (2013)
Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury
Massimo Collino et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Correlation With Outcomes
Marco Metra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
Design of the RELAXin in Acute Heart Failure Study
Piotr Ponikowski et al.
AMERICAN HEART JOURNAL (2012)
Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure? The Role of Congestion and Its Interaction With Renal Function
Marco Metra et al.
CIRCULATION-HEART FAILURE (2012)
The role of the kidney in heart failure
Marco Metra et al.
EUROPEAN HEART JOURNAL (2012)
Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure
Kevin Damman et al.
HEART (2012)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
Lesley A. Inker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease
R. Hojs et al.
CLINICAL NEPHROLOGY (2011)
Sympatho-renal axis in chronic disease
Paul A. Sobotka et al.
CLINICAL RESEARCH IN CARDIOLOGY (2011)
Relaxin-Induced Changes in Renal Function and RXFP1 Receptor Expression in the Female Rat
Alsadek H. Bogzil et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse Cutaneous Involvement A Randomized, Double-Blind, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2009)
Differential associations between renal function and modifiable risk factors in patients with chronic heart failure
Tom D. J. Smilde et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Relaxin and the progression of kidney disease
Chrishan S. Samuel et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)
Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers
Marie C. Smith et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function - A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database
CW Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Multiplicity in randomised trials II: subgroup and interim analyses
KF Schulz et al.
LANCET (2005)
Relaxin-induced changes in renal sodium excretion in the anesthetized male rat
AH Bogzil et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2005)
Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test
ST Brookes et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure
MW Akhter et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats
LA Danielson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2003)
Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
VR Dharnidharka et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Activation of orphan receptors by the hormone relaxin
SY Hsu et al.
SCIENCE (2002)
The pregnancy hormone relaxin is a player in human heart failure
T Dschietzig et al.
FASEB JOURNAL (2001)
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment
E Coll et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
